HMGB1 is upregulated in the airways in asthma and potentiates airway smooth muscle contraction via TLR4

Journal of Allergy and Clinical Immunology

Volumn 140, Issue 2, 2017, Pages 584-587.e8

  Di Candia, Leonarda ^a   Gomez, Edith ^a   Venereau, Emilie ^b   Chachi, Latifa ^a   Kaur, Davinder ^a   Bianchi, Marco E ^b   Challiss, R A John ^a   Brightling, Christopher E ^a   Saunders, Ruth M ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; COLLAGEN GEL; CORTICOSTEROID; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER; HMGB1 PROTEIN, HUMAN;

AIRWAY; AIRWAY SMOOTH MUSCLE CELL; ARTICLE; ASTHMA; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; IMMUNOHISTOCHEMISTRY; MUSCLE CONTRACTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RESPIRATORY TRACT INFLAMMATION; UPREGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETICS; METABOLISM; RESPIRATORY SYSTEM; SMOOTH MUSCLE; SPUTUM;

ASTHMA; BIOMARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HMGB1 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RESPIRATORY SYSTEM; SPUTUM; TOLL-LIKE RECEPTOR 4;

EID: 85014126674     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.11.049     Document Type: Article

References (18)

1. Doeing, D.C., Solway, J., Airway smooth muscle in the pathophysiology and treatment of asthma. J Appl Physiol (1985) 114 (2013), 834–843.
2. Hou, C., Zhao, H., Liu, L., Li, W., Zhou, X., Lv, Y., et al. High mobility group protein B1 (HMGB1) in asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med 17 (2011), 807–815.
3. Hou, C., Kong, J., Liang, Y., Huang, H., Wen, H., Zheng, X., et al. HMGB1 contributes to allergen-induced airway remodeling in a murine model of chronic asthma by modulating airway inflammation and activating lung fibroblasts. Cell Mol Immunol 12 (2015), 409–423.
4. Magna, M., Pisetsky, D.S., The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol Med 20 (2014), 138–146.
5. Sutcliffe, A., Hollins, F., Gomez, E., Saunders, R., Doe, C., Cooke, M.S., et al. Increased nicotinamide adenine dinucleotide phosphate oxidase 4 expression mediates intrinsic airway smooth muscle hypercontractility in asthma. Am J Respir Crit Care Med 185 (2012), 267–274.
6. Watanabe, T., Asai, K., Fujimoto, H., Tanaka, H., Kanazawa, H., Hirata, K., Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients. Respir Med 105 (2011), 519–525.
7. + T cell responses via high mobility group box-1 in the pathogenesis of asthma. Allergy Asthma Immunol Res 7 (2015), 190–194.
8. Ito, I., Fukazawa, J., Yoshida, M., Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J Biol Chem 282 (2007), 16336–16344.
9. Zhang, C., Mo, M., Ding, W., Liu, W., Yan, D., Deng, J., et al. High-mobility group box 1 (HMGB1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (SR) Ca(2+) leak through TLR4-ROS signaling in cardiomyocytes. J Mol Cell Cardiol 74 (2014), 260–273.
10. Lee, C.C., Lai, Y.T., Chang, H.T., Liao, J.W., Shyu, W.C., Li, C.Y., et al. Inhibition of high-mobility group box 1 in lung reduced airway inflammation and remodeling in a mouse model of chronic asthma. Biochem Pharmacol 86 (2013), 940–949.
11. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA) 2014. Available at: http://www.ginasthma.org. Updated 2016. Accessed May 16, 2016.
12. Pavord, I.D., Pizzichini, M.M., Pizzichini, E., Hargreave, F.E., The use of induced sputum to investigate airway inflammation. Thorax 52 (1997), 498–501.
13. Schlueter, C., Hauke, S., Flohr, A.M., Rogalla, P., Bullerdiek, J., Tissue-specific expression patterns of the RAGE receptor and its soluble forms–a result of regulated alternative splicing?. Biochim Biophys Acta 1630 (2003), 1–6.
14. Liu, R., Mori, S., Wake, H., Zhang, J., Liu, K., Izushi, Y., et al. Establishment of in vitro binding assay of high mobility group box-1 and S100A12 to receptor for advanced glycation end-products: heparin's effect on binding. Acta Med Okayama 63 (2009), 203–211.
15. Zeng, S., Dun, H., Ippagunta, N., Rosario, R., Zhang, Q.Y., Lefkowitch, J., et al. Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury. J Hepatol 50 (2009), 929–936.
16. Yang, S., Yang, T.-S., Wang, F., Su, S.-B., High-mobility group box-1-Toll-like receptor 4 axis mediates the recruitment of endothelial progenitor cells in alkali-induced corneal neovascularization. Int Immunopharmacol 28 (2015), 450–458.
17. Zou, J., Crews, F.T., Glutamate/NMDA excitotoxicity and HMGB1/TLR4 neuroimmune toxicity converge as components of neurodegeneration. AIMS Mol Sci 1 (2015), 77–100.
18. Woodman, L., Siddiqui, S., Cruse, G., Sutcliffe, A., Saunders, R., Kaur, D., et al. Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-β1. J Immunol 181 (2008), 5001–5007.